Aydin State Hospital, Plastic, Reconstructive and Aesthetic Surgery Clinic, 09100, Aydin, Turkey.
Aksaray University Training and Research Hospital, Plastic, Reconstructive and Aesthetic Surgery Clinic, 68200, Aksaray, Turkey.
Aesthetic Plast Surg. 2021 Oct;45(5):2328-2337. doi: 10.1007/s00266-021-02297-1. Epub 2021 May 10.
Face rejuvenation procedures with injectable agents continue to gain popularity. Nowadays, a variety of commercial products are available as filler material. Ideal fillers should be inexpensive, easily obtainable, nontoxic, and biocompatible. The aim of this study is to report a clinical perspective for an appropriate, feasible, and inexpensive protocol of a stable, autologous biological filler for facial volume restoring without any commercial kits.
Eight patients were investigated who underwent facial injection with ABC filler. Eleven ml of whole blood was placed in standard tubes containing anticoagulant and for each patient, 8 tubes were prepared. After the centrifugation at 1630 xg for 5 minutes, the upper plasma was taken, calcium was added and cooled. After the addition of vitamin C, the syringes were incubated at 85 °C for 10 minutes. The autologous biological material obtained was used as filling material. For comparison, FACE-Q satisfaction questionnaires were used before and after the procedure.
All patients were followed up for a minimum of 4 months. No major complications were recorded. The patient-reported FACE-Q satisfaction and FACE-Q quality of life pre- and post-procedure results showed statistically significant improvement (p < 0.05). Overall satisfaction with the outcome was 89.12 ± 16.73 (range 55-100).
ABC filler can be seen as a reliable, inexpensive, and easily obtainable material to restore facial volume with increased patient satisfaction and quality of life scores. We believe that our study will be encouraging to the application of autologous biological fillers for further clinical and scientific studies.
This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
注射用制剂进行面部年轻化治疗的方法不断普及。目前,有多种商业产品可用作填充材料。理想的填充物应价格低廉、易于获得、无毒且生物相容性好。本研究旨在报告一种合适、可行且经济的面部容量恢复方案,该方案使用稳定的、自体生物填充剂,无需任何商业套件。
对 8 例接受 ABC 填充物面部注射的患者进行了研究。每位患者采集 11ml 全血,置于含抗凝剂的标准管中,共准备 8 管。离心(1630xg,5 分钟)后,吸取上层血浆,加入钙并冷却。加入维生素 C 后,将注射器在 85°C 下孵育 10 分钟。获得的自体生物材料用作填充材料。为了进行比较,在治疗前后使用 FACE-Q 满意度问卷进行评估。
所有患者均至少随访 4 个月。未记录到重大并发症。患者报告的治疗前后 FACE-Q 满意度和 FACE-Q 生活质量结果显示出统计学上的显著改善(p<0.05)。总体满意度为 89.12±16.73(55-100 分)。
ABC 填充物可作为一种可靠、经济且易于获得的材料,可恢复面部容量,提高患者满意度和生活质量评分。我们相信,我们的研究将鼓励进一步的临床和科学研究应用自体生物填充物。
证据等级 IV:本期刊要求作者为每篇文章指定一个证据等级。有关这些循证医学评级的完整描述,请参考目录或在线作者指南 www.springer.com/00266 。